The UK General Election on 8 June 2017 presents a real opportunity for the new Government to set out a clear strategy to secure and grow the UK's status as a global hub for the pharmaceutical industry and improve patients' access to the medicines they need.
Check back for ABPI analysis which will follow the publication of the following political party manifestos:
On 27 April, we were the first UK business lobby group to publish a manifesto for the upcoming General Election.
'Securing the Opportunity for UK Life Sciences by 2022' sets out the UK pharmaceutical industry's policy priorities for the next parliament.
A strategy to make patient outcomes in the NHS the best in the world. This should start by increasing health care investment to the G7 average and ensuring the UK is in the top quartile of OECD countries for patient access to new cost effective medicines and vaccines by 2022.
A new industrial strategy that cements the UK's position as a leading global hub for the life science and pharmaceutical industry, attracting significant new international investment.
A new relationship with the European Union that secures patient access to medicines and protects public health.
For further information, please email the ABPI Press Office.
For further information, please contact ABPI's Head of External Affairs, Elliot Dunster.